Cetaphil Restoraderm I.R. Gel Launched by Galderma for Instant Itch Relief in Atopic Dermatitis
Galderma India has launched Cetaphil Restoraderm I.R. Gel, to provide instant itch relief in individuals with atopic dermatitis (AD)1.
Atopic dermatitis is commonly associated with persistent itching, which can trigger the itch-scratch cycle. Repeated scratching damages skin barrier, perpetuating inflammation and cytokine release that further promote itching. It can also compromise the skin barrier, contributing to ongoing inflammation and skin-barrier dysfunction2. Breaking this cycle promptly through appropriate management is therefore an important part of effective itch control.
In India, the prevalence of atopic dermatitis (AD) has been reported to be increasing, potentially influenced by changing environmental factors. Studies involving both paediatric and adult populations have reported AD prevalence ranging from 0.98% to 9.2%3. The most commonly reported symptoms include itching, dryness and sleep disturbances, with itch severity correlating with disease severity in more than 60% of patients4.
To calm the itching skin, Cetaphil Restoraderm I.R. Gel is developed as an ultra-lightweight gel, designed to have a unique cool-touch applicator with a 100% stainless-steel roller, which delivers an immediate cooling sensation and high thermal conductivity that helps reduce heat on the skin¹. The formulation is available in a patient-friendly, practical, easy-to-carry on-the-go size1.
According to Galderma, Cetaphil Restoraderm I.R. Gel provides complete itch relief within 30 seconds, with claims of itch relief lasting up to 12 hours, hydration for up to 48 hours and skin-barrier protection for up to eight hours1.
Cetaphil Restoraderm I.R. Gel contains SymCalmin® with Colloidal Oats, Ad-Resyl®, Ceramides and Filaggrin Technology™, which address itch comprehensively and support the skin barrier5.
SymCalmin® with Colloidal Oats helps to break the itch-scratch cycle by modulating neurokinin-1 receptor activation and reducing histamine release associated with the itch sensation5,6. Ad-Resyl® targets four key drivers of atopic dermatitis, including restoring skin-barrier function, supporting microbiome balance, soothing the skin, and helping calm neural hyperreactivity7,5.
Lastly, Filaggrin Technology™ delivers natural moisturising factors such as pyrrolidone carboxylic acid (PCA) and arginine, which support hydration and strengthen the skin barrier8,9,5.
Cetaphil is a dermatologist-recommended skincare brand with more than 70 years of experience, offering formulations designed for sensitive skin and skin-barrier care.
Galderma is the pure-play dermatology category leader, present in approximately 90 countries. It deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
IN-CET-2600930
Disclaimer: For use of registered medical practitioner only.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.